Cargando…
SUN-183 Adrenalitis Induced by Nivolumab
Introduction: Tumor cells often express a programmed death-ligand 1 (PD-L1), which binds to the programmed death receptor-1 (PD-1) on activated T-cells to induce immune tolerance. Among the class of immune checkpoint inhibitors (ICI), Nivolumab is an anti-PD-1 antibody which blocks these tumor cell...
Autores principales: | Khan, Muhammad Atique Alam, Iqbal, Iqra, Dhillon, Puneet, Ullah, Waqas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208067/ http://dx.doi.org/10.1210/jendso/bvaa046.041 |
Ejemplares similares
-
SAT-183 Right Adrenal Mass: An Unusual Presentation
por: Gondin-Hernandez, Lyan, et al.
Publicado: (2020) -
SUN-170 Adrenal Insufficiency Due to Adrenal Hemorrhage
por: Bansal, Rashika, et al.
Publicado: (2020) -
MON-183 Adrenal Androgen Control and Steroidal Side Effects in Adolescents and Adults with Congenital Adrenal Hyperplasia Treated with Glucocorticoids
por: Falhammar, Henrik, et al.
Publicado: (2020) -
SUN-164 Adrenal Crisis in Early Pregnancy
por: Bello, Jenny Carolina, et al.
Publicado: (2020) -
SUN-388 Immune Checkpoint Inhibitor Nivolumab in Advanced or Recurrent Adrenocortical Carcinoma
por: Akunjee, Munaza, et al.
Publicado: (2019)